Email ID
Password
Sign me in automatically next time
Scrip Regulatory Affairs
Australia increases product registration fee under new IVD framework
25 March 2010
Vibha Sharma

Australian in vitro diagnostic companies wanting to market their products under the newly-enacted IVD framework will have to pay a fee of Aus$790 (US $720) to register their products with the Therapeutic Goods Administration1,2.

The agency had previously said that the product registration fee would be Aus$300, but has since decided to align its IVD pricing schedule with that of medical devices, as the work involved in processing both types of application is the same3...

Please login to read the full article.
 
 
 
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
   
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36